1200 mg, coated tablets
Piracetamum
Piracetam, the active substance of Lucetam, is a nootropic agent, which means it stimulates brain metabolism. It reduces blood viscosity, increases blood flow through brain vessels without vasodilating effects, and also increases oxygen and glucose utilization in ischemic brain tissue.
Before taking Lucetam, inform your doctor or pharmacist:
Tell your doctor about all medicines you are taking, have recently taken, or plan to take.
Remember to inform your doctor about taking thyroid hormones or anticoagulant medications. Concomitant use of these medicines with Lucetam requires close medical supervision or modification of the doses used.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Lucetam should only be used during pregnancy if clearly necessary. The doctor will only prescribe this medicine if the benefits of its use in individual cases outweigh the risk to the baby.
Breastfeeding
Piracetam is excreted in human milk. Therefore, Lucetam should not be used during breastfeeding, or breastfeeding should be discontinued during treatment with Lucetam.
Given the adverse events observed during the use of Lucetam, the medicine may affect the ability to drive and use machines, which should be taken into account. In this regard, the doctor will determine the appropriate restrictions.
Take this medicine always as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Recommended dose
The dose and duration of treatment should be determined individually by the doctor, depending on the type and severity of the disease, age, and other diseases.
Tablets should be taken with food or independently of food and washed down with 100-200 ml of liquid.
It is recommended to divide the daily dose into 2-4 equal parts.
Recommended daily doses depending on the indication:
Treatment of central nervous system-derived muscle tremors (cortical myoclonus):
The recommended initial dose is 7.2 g per day. If necessary, this dose can be increased by 4.8 g every 3-4 days, up to a maximum dose of 24 g, given in 2 or 3 divided doses.
Treatment of dizziness
The recommended daily dose ranges from 2.4 g to 4.8 g, given in 2 or 3 divided doses.
In cases of renal insufficiency, dose adjustment may be necessary.
To improve learning outcomes in children with learning difficulties and dyslexic disorders (in combination with other methods):
In adolescents and children from 8 years of age, the recommended daily dose is approximately 3.2 g, given in 2 divided doses. It is used in combination with speech therapy.
In case of overdose, seek medical attention immediately.
Do not take a double dose to make up for a missed dose. If you miss a dose at the scheduled time, take the missed dose as soon as possible before the next dose. If it is already time for the next dose, skip the missed dose, as there is a risk of overdose if two doses are taken at once.
Do not stop taking Lucetam without consulting your doctor first.
If you have any further doubts about the use of this medicine, consult your doctor or pharmacist.
Like all medicines, Lucetam can cause side effects, although not everybody gets them.
If you experience any of the following symptoms, stop taking Lucetam and seek immediate medical attention:
The following side effects have been reported:
Common side effects(may affect up to 1 in 10 people):
Hyperkinesia (involuntary and excessive movement, usually of skeletal muscles), weight gain, nervousness.
Uncommon side effects(may affect up to 1 in 100 people):
Weakness, drowsiness, depression.
Side effects of unknown frequency(frequency cannot be estimated from available data):
Coagulation disorders, excitement, anxiety, confusion, hallucinations, ataxia (coordination disorders), balance disorders, exacerbation of epilepsy, headaches, insomnia, dizziness, abdominal pain, epigastric pain, diarrhea, nausea, and vomiting, skin inflammation, skin itching.
If you experience any side effects, including any side effects not listed in this leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C 02-
222 Warsaw
Phone: + 48 22 49 21 301
Fax: + 48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of this medicine.
Do not store above 30°C.
Keep out of sight and reach of children.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is piracetam.
Each coated tablet contains 1200 mg of piracetam. The other ingredients are: magnesium stearate, povidone K 30, coating (macrogol 6000, dibutyl sebacate, titanium dioxide (E 171), talc, ethylcellulose, hypromellose).
White or almost white, oval, biconvex tablets with the inscription "E 243" on one side. Egis Gyógyszergyár Zrt. Egis Gyógyszergyár Zrt. Medezin Sp. z o.o. Medezin Sp. z o.o. [Information about the trademark]
A brown glass bottle with a plastic cap and a ring seal, in a cardboard box, containing 60 coated tablets.Marketing authorization holder in Hungary, the country of export:
Keresztúri út 30-38.
H-1106 Budapest, HungaryManufacturer:
Mátyás király utca 65.
H-9900 Körmend, HungaryParallel importer:
ul. Zbąszyńska 3
91-342 ŁódźRepackaged by:
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Hungary, the country of export: OGYI-T- 7153/09Parallel import authorization number: 218/25
Date of leaflet approval: 26.06.2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.